Nystatin starts killing fungal cells on contact, but the time it takes to resolve an infection depends heavily on where that infection is. For surface skin infections caused by Candida, studies show the fungus can be cleared in as little as two to three days. Oral thrush, on the other hand, typically requires at least one to two weeks of treatment, and cure rates with nystatin suspension are surprisingly variable. The drug’s effectiveness is shaped by factors that go well beyond the molecule itself, from the formulation you use to how long it stays in contact with the infected tissue.
How Nystatin Destroys Fungal Cells
Nystatin works by targeting ergosterol, a molecule found in fungal cell membranes but not in human cells. Research into its mechanism has revealed a two-stage process. At low concentrations, nystatin molecules sit on the surface of the fungal membrane and disrupt its structure, making the membrane leaky. Once enough nystatin accumulates, it shifts to a second mode: forming channels that punch through the membrane entirely, allowing the cell’s contents to spill out and killing it.1Biophysical Journal. Interaction of Nystatin with Ergosterol- and Cholesterol-Containing Biomembranes: A Comparative Study This means nystatin is fungicidal, not just fungistatic. It does not merely slow fungal growth; it destroys the cells outright, provided enough drug reaches the site.
That “provided enough drug reaches the site” caveat is the key to understanding why nystatin works fast in some situations and slowly in others. Nystatin is essentially not absorbed into the bloodstream. When applied topically to skin, permeation studies confirm the drug stays in the local tissue rather than entering systemic circulation.2PubMed. Evaluation of novel nystatin nanoemulsion for skin candidosis infections When taken as an oral suspension, it passes through the gut largely unabsorbed. This local-only action is both a safety advantage and a limitation: nystatin works well where it can make direct contact with the fungus, and poorly where it cannot.
Skin Infections Can Clear Within Days
Topical nystatin cream applied to Candida skin infections tends to work quickly. In a comparative study of patients with perianal candidosis, topical nystatin cream cleared the Candida organism in every patient within five days, with an average clearance time of about three days.3PubMed. Perianal candidosis–a comparative study with mupirocin and nystatin That is the mycological result, meaning the fungus itself was gone.
The clinical picture was less tidy. Even after the Candida was eliminated, most patients in that study still had ongoing skin irritation and inflammation caused by other bacteria colonizing the damaged tissue. Only three out of ten wounds were fully healed within the trial period. So while nystatin can knock out a superficial Candida infection on skin in just a few days, the skin itself may take longer to look and feel normal, especially if the area was already raw or broken down. If you are applying nystatin cream for a yeast-related diaper rash or skin fold infection, expect the yeast to respond within the first few days, but give the irritated skin a bit more time to recover.
Oral Thrush Takes Longer
Oral candidiasis, or thrush, is the most common reason people are prescribed nystatin, and it is also where the drug’s limitations show most clearly. A systematic review of clinical trials found that using nystatin suspension for two weeks produced clinical cure rates ranging from about 9% to 64%, depending on the patient population.4PubMed Central. Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis That is a wide spread, and it reflects real differences in how well the drug works across groups like otherwise healthy infants, denture wearers, and people with HIV/AIDS.
Mycological cure rates, meaning complete elimination of the Candida from culture, were even lower in that same review, hovering between roughly 6% and 13% with suspension. This does not mean nystatin is useless for oral thrush; many patients see significant symptom improvement without achieving a full mycological cure. But it does mean that if your doctor prescribes a two-week course, you should expect gradual improvement rather than a rapid fix. The white patches and soreness typically begin to fade within the first several days, though some patients need to complete the full course before symptoms fully resolve.
Contact time is a major reason oral thrush is harder to treat than skin infections. Nystatin suspension is swished around the mouth and swallowed, but saliva dilutes the drug and swallowing removes it from the oral mucosa within minutes. Researchers have explored formulations designed to extend that contact time, such as pastilles that take roughly 17 minutes to dissolve in the mouth, compared with the seconds a liquid suspension remains in contact with tissue.5Pharmaceutical Development and Technology. Nystatin and lidocaine pastilles for the local treatment of oral mucositis This is also why newer formulations, including mucoadhesive lozenges, are being developed to keep the drug in place longer and improve local efficacy.6PubMed Central. Designing, Characterization, and Optimization of Nystatin Loaded Mucoadhesive Spanlastical Hard Candy Lozenges as a Treatment of Oral Candidiasis
Denture Stomatitis Is Particularly Stubborn
Denture-related stomatitis, the chronic red irritation under dentures caused by Candida colonization, presents a particular challenge. The fungus forms biofilms on denture surfaces, which are structured communities of organisms embedded in a protective matrix. Biofilms are much harder to penetrate with antifungal agents than free-floating yeast cells. In a clinical trial evaluating nystatin for denture stomatitis over 14 days, both a nystatin-only group and a nystatin-plus-curcumin group saw significant reductions in Candida colony counts and in the size of the red, inflamed areas.7PubMed Central. Comparative Antifungal Efficacy of Curcumin Plus Nystatin Versus Nystatin Monotherapy for Treatment of Denture Stomatitis But denture stomatitis is notorious for recurring once treatment stops, because the denture itself can harbor residual fungus.
If you are dealing with denture-related thrush, expect at least two weeks of treatment and understand that the drug is fighting not just the yeast in your tissue but also the biofilm on the prosthesis. Cleaning the denture thoroughly alongside nystatin treatment is essential, and even then, recurrence rates are high.
Why Nystatin Cannot Reach the Gut or Bloodstream
A common misconception is that swallowing nystatin suspension treats intestinal Candida overgrowth. It generally does not. Because nystatin is barely absorbed from the gastrointestinal tract, swallowed doses pass through without reaching effective concentrations in the intestinal lining. A prospective study in patients with inflammatory bowel disease compared swish-and-spit nystatin with oral fluconazole. Fluconazole, which is absorbed into the bloodstream and reaches the gut from within, effectively reduced intestinal Candida burden. Nystatin did not.8Nature Medicine. Antifungal therapy improves microbiome dynamics in inflammatory bowel disease
This same non-absorbable property is also why nystatin is not used for systemic fungal infections like candidemia, fungal pneumonia, or disseminated candidiasis. For those conditions, drugs that enter the bloodstream, such as fluconazole, amphotericin B, or echinocandins, are required. Nystatin’s role is fundamentally local: mouth surfaces, skin, and vaginal tissue.
How Nystatin Stacks Up Against Fluconazole
For oral thrush specifically, fluconazole has generally outperformed nystatin in head-to-head trials, both in speed and in overall cure rates. In one trial of adult patients, seven days of fluconazole produced improvement in 87% of patients, while nystatin required 21 days of treatment (three times longer) and achieved improvement in 80%.9PubMed. Fluconazole versus nystatin in the treatment of oral candidosis The cure rates look comparable at first glance, but getting to a similar result in one-third the time is a meaningful clinical advantage.
The difference is starker in infants. A pilot study comparing the two drugs in otherwise healthy babies with oral thrush found a 100% clinical cure rate with fluconazole versus 32% with nystatin suspension.10PubMed. Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants That is a dramatic gap, and it helps explain why some pediatricians reach for fluconazole first. The likely reason for the disparity is contact time again: getting an infant to hold a nystatin suspension in their mouth long enough for it to work is nearly impossible, while fluconazole is swallowed once daily and works from the bloodstream.
So why is nystatin still prescribed at all? A few reasons. It has an extremely low risk of systemic side effects because it is not absorbed. It has no meaningful drug interactions, which matters for patients on complex medication regimens. Fluconazole, by contrast, interacts with a long list of medications because it inhibits liver enzymes involved in drug metabolism. For mild thrush in patients who can hold the suspension in their mouth for a reasonable time, nystatin remains a sensible first-line option. It also avoids contributing to the growing problem of azole-resistant Candida strains, a concern that has made infectious-disease specialists more cautious about prescribing fluconazole for every minor yeast infection.
What Can Slow or Stall Treatment
Several factors determine whether nystatin works quickly or drags on:
- Immune status: People with weakened immune systems, whether from HIV, chemotherapy, or immunosuppressive drugs, respond less reliably to nystatin. The wide range of cure rates in the oral thrush literature largely reflects this variable. In patients with well-functioning immunity, mild thrush often responds within a week. In severely immunocompromised patients, nystatin alone may not be enough.
- Adherence and technique: Nystatin suspension needs to be swished around the mouth for as long as possible before swallowing. Patients who gulp it down quickly, or who eat and drink immediately after, reduce the drug’s contact time with the infected tissue and can expect worse results.
- Biofilm formation: Candida growing in a biofilm on a denture, implant, or other surface is more resistant to treatment than Candida floating freely on mucosal tissue. Biofilm-associated infections take longer to resolve and recur more often.
- Candida species: While Candida albicans is the most common cause of thrush, non-albicans species like C. glabrata and C. krusei are inherently less susceptible to some antifungals. Nystatin retains activity against most Candida species, but the speed of clearance can vary.
Resistance to nystatin is uncommon compared to resistance to azole antifungals, but it does occur. Case reports have documented Candida albicans isolates developing resistance to nystatin, particularly when the drug was used in combination with a corticosteroid like triamcinolone acetonide. The corticosteroid appears to have promoted conditions allowing resistant strains to emerge. If your thrush is not responding after a full course of nystatin, the issue may be resistance, an underlying immune problem, or a non-Candida cause of the symptoms, all of which warrant follow-up.
Side Effects Are Mild but Can Undermine Compliance
Nystatin’s safety profile is genuinely excellent for an antifungal. Because it stays local, it does not stress the liver or kidneys the way systemic antifungals can. A systematic review of clinical trials found that adverse effects were reported in only about a quarter of studies that tracked them, and the problems that did come up were mild: nausea, vomiting, unpleasant taste, and diarrhea.11PubMed Central. Nystatin Effectiveness in Oral Candidiasis Treatment: A Systematic Review & Meta-Analysis of Clinical Trials
The “unpleasant taste” item deserves special emphasis because it is the side effect most likely to interfere with treatment speed. Nystatin suspension has a notoriously bitter, medicinal flavor. Adults may tolerate it; infants and young children often spit it out or refuse it. If you cannot keep the medication in contact with the infection, it cannot work, and a two-week course that is only half-heartedly followed will produce poor results. For patients who find the suspension unbearable, asking about alternative formulations like pastilles or lozenges can help.
The Lingering Effect After Nystatin Is Gone
One underappreciated aspect of nystatin’s action is its post-antifungal effect, the period after drug exposure during which fungal growth remains suppressed even though the drug itself is no longer present. In laboratory studies of oral Candida species, nystatin produced a post-antifungal suppression lasting between about 7 and 15 hours, depending on the species. Candida albicans showed the shortest suppression at roughly 7 hours, while Candida parapsilosis showed the longest at about 15 hours. Other species like C. tropicalis and C. krusei fell in between, at roughly 13 and 12 hours respectively.12Wiley Online Library. The in vitro post-antifungal effect of nystatin on Candida species of oral origin
This matters practically because it means nystatin continues working in between doses. The typical dosing schedule of four times daily is partly justified by this residual suppression. It also means that if you miss a dose by an hour or two, the antifungal pressure has not completely dropped off. That said, these are laboratory measurements under controlled conditions, and the effect in a living mouth, with saliva flow, eating, and drinking, is likely shorter. Consistent dosing still matters.
How Nystatin Got Its Name
Nystatin was the first antifungal drug ever developed, isolated in the late 1940s by two scientists, Elizabeth Lee Hazen and Rachel Fuller Brown, working at the New York State Department of Health. They found the compound in a soil bacterium called Streptomyces noursei and originally named it fungicidin before renaming it nystatin as a nod to “NY State.”13Nature Reviews Microbiology. Unearthing the story of the first antifungal drugs Despite being discovered more than 70 years ago, nystatin remains in clinical use worldwide, largely because fungal resistance to it has stayed relatively rare and because its lack of systemic absorption makes it one of the safest antifungals available. Newer and more potent antifungals have been developed since, but nystatin continues to fill a role that no other drug occupies quite as well: a topical antifungal with a wide spectrum of activity against Candida species and an almost negligible risk of systemic harm.